JOAQUIN GARCIA-LOPEZ

DIRECTOR
MARKET RESEARCH EXCELLENCE
GLOBAL COMMERCIAL STRATEGY ORGANIZATION

Joaquin Garcia-Lopez is Director, Market Research Excellence for the Global Commercial Strategy Organization (GCSO) at Janssen. In this role, Joaquin is responsible for driving functional excellence in market research across the global team, bringing together analytics professionals in GCSO and regional commercial roles to accelerate best practice sharing regarding market research methodologies and implementation. He partners with market researchers within GCSO Therapy Area teams to drive cutting-edge research to support development decisions for compounds in Janssen’s R&D pipeline. His focus includes providing guidance on reliable methods for unearthing rich patient emotional and rational insights to fuel asset strategies throughout the disease continuum and product life cycles.

Joaquin joined Janssen in 2015 as Associate Director of Global Market Research for the Neurodegeneration Disease Area Stronghold within GCSO. In this role, Joaquin was responsible for the generation of actionable customer analytics and insights to help the Neurodegeneration team identify ways to build and maximize the value of its global pipeline assets. He was the market research lead on a wide range of programs related to the future management of preclinical Alzheimer’s disease and served as commercial lead for the alpha-2C inhibitor asset and atabecestat’s EARLY trial communications program.

In his previous role, Joaquin was Vice President of healthcare research at ORC International, a market research and business intelligence firm. In this role, he worked with a broad portfolio of pharmaceutical clients and led consultative market analytics meeting a range of business needs such as new product development, lifecycle management strategies and various drug launches.  Joaquin started his pharmaceutical career as a bench biomedical engineer at Forticell Bioscience’s process development group, where he worked on the development and launch of novel cell therapies and advanced biomaterials.

Joaquin graduated from Columbia University with both an Master of Science in Technology Management and a Bachelor of Science in Biomedical Engineering and holds a B.A. in Mathematics from Fordham University.